IL-1β prompts immune cell infiltration into damaged tissues, and studies indicate that IL-1β receptor antagonists exhibit promising therapeutic effects on gouty arthritis and GN (Schlesinger et al., 2023b). The gene discussed is IL1B; the disease is ganglioneuroma.